Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 2, 2021
Clear
SKU: GMS-1246 Category:

OVERVIEW

The Point of Care Molecular Diagnostics Market is expected to reach USD 2.68 billion by 2026, growing at a CAGR of 8% during the forecast period. The drivers of this market include the increasing awareness regarding early disease diagnosis for better management of infections, which has a positive impact on the market demand. Several initiatives undertaken by government in underdeveloped and developing regions to create awareness about infectious diseases and prevention is propelling the market growth. Rising incidence of infectious diseases like COVID-19 has stimulated the demand for point of care molecular diagnostic equipment to identify causative agents and further control the spread of disease. Thus, increasing the demand for such products in the market.

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 1

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 2

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 3

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 4

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 5

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 6

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 7

Point of Care Molecular Diagnostics Market by Technology, Service (Software, Assays, Analyzers, Kits), Application (Hospital Acquired Infection, Respiratory Disease), Product & End User (Physician Office, ICUS) – 2021 to 2026 8

TABLE OF CONTENT

1 Global Point of Care Molecular Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Point of Care Molecular Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Point of Care Molecular Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Point of Care Molecular Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Point of Care Molecular Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Point of Care Molecular Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Point of Care Molecular Diagnostics Market – By Product & Service (Market Size – &
million/billion)
8.1 Assays & Kits
8.2 Instruments/Analyzers
8.3 Services & Software

9 Global Point of Care Molecular Diagnostics Market – By Application
9.1 Respiratory diseases
9.2 STDs
9.3 HAIs
9.4 Oncology
9.5 Hepatitis
9.6 Other

10 Global Point of Care Molecular Diagnostics Market – By Technology
10.1 RT-PCR
10.2 INAAT
10.3 Others

11 Global Point of Care Molecular Diagnostics Market – By End-User
11.1 Physician Offices
11.2 Hospital Emergency Departments & Intensive Care Units
11.3 Research Institutes
11.4 Other

12 Global Point of Care Molecular Diagnostics Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Point of Care Molecular Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Point of Care Molecular Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories
14.3 Danaher Corporation
14.4 Biomérieux Sa
14.5 Meridian Bioscience
14.6 Roche Diagnostics
14.7 DxNA
14.8 Quidel
14.9 Mesa Biotech
14.10 Genepoc
14.11 Atlas Genetics
14.12 Company 11 & more

15 Global Point of Care Molecular Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations